AVITA Medical Establishes Proof of Concept for Novel Treatments Using Genetically-Modified Skin Cells

AVITA Medical, Inc. announced that preclinical data successfully established proof of concept in two key areas of cell-based gene therapy – skin rejuvenation and epidermolysis bullosa.